Over the total 78 weeks observed, there were no overdose events in the extended-release naltrexone group and seven in the usual-treatment group
Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders Background Extended-release naltrexone, a sustained-release monthly injectable formulation of the full mu-opioid …
